Sarah Mackie

42PUBLICATIONS
315CO-AUTHORS
Toxicology (incl. clinical toxicology)Predictive and prognostic markersMedical infection agents (incl. prions)Pacific Peoples and disabilityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Oct 13, 2026
The 2026 British Society for Rheumatology guideline for the treatment of polymyalgia rheumatica.

|Sep 01, 2026
Scoping review of clinical, laboratory, histopathological and imaging predictors of relapse in adults with biopsy- or temporal artery ultrasound-confirmed giant cell arteritis on standard therapy with glucocorticoids alone or in combination with biologics.

|Feb 11, 2026
Patient experiences of PMR: a qualitative narrative literature review.

Max Yates, Janice Mooney, Pratyasha Saha

|Jan 05, 2026
Patient perspectives on life impact and unmet needs in giant cell arteritis and polymyalgia rheumatica: insights from social media.

Sarah L Mackie, Pallavi Arun, Vandana Padmanabhan

|Aug 26, 2025
Coming to a hard stop? Effect of tapered tocilizumab after weekly tocilizumab cessation for GCA: a multicentre evaluation.

Vanessa Quick, Stephen Sah, Shirish Dubey

|Feb 07, 2025
Age, anticoagulants, hypertension and cardiovascular genetic traits predict cranial ischaemic complications in patients with giant cell arteritis.

Natalie J M Chaddock, Charlotte J Harden, Louise Sorensen

Pageof 7

Frequent Collaborators

10 joint publications

Joanna Robson

6 joint publications

Catherine L Hill

5 joint publications

Helen Twohig

5 joint publications

Ann W Morgan